Current knowledge on fatty acids in cystic fibrosis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 3, 1996, Pages 129-138

  Christophe, A ^a,b   Robberecht, E ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; FATTY ACID; LINOLEIC ACID; LIPID; PANCREAS EXTRACT; PHOSPHOLIPID; TRIACYLGLYCEROL;

CYSTIC FIBROSIS; DIET; FATTY ACID OXIDATION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; REVIEW;

EID: 0029910787     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90087-3     Document Type: Review

References (125)

1. Park R. W., Grand R. J. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology 1981; 81: 1143-1161.
2. McPherson M. A., Goodchild M. C. The biochemical defect in cystic fibrosis. Clin Sci 1988; 74: 337-345.
3. Rommens J. M., Iannuzzi M. C., Kerem B. S. et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
4. Dork T., Mecus F., Schmidt K. et al. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet 1994; 533-542.
5. Riordan J. R., Rommens J. M., Kerem B.-S. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1072.
6. + pump in parallel to a chloride conductance. J Cell Biol 1983; 97: 1303-1308.
7. Al-Awqati Q. Pathophysiology of cystic fibrosis. In: Abstract Book 20th European Cystic Fibrosis Conference, Brussels, Belgium 1995: OL1-8.
8. Caren R., Corbo L. Plasma fatty acids in pancreatic cystic fibrosis and liver disease. J Clin Endocrinol 1966; 26:470-477.
9. Underwood B. A., Denning C. R., Navab M. Polyunsaturated fatty acid and tocopherol levels in patients with cystic fibrosis. Ann NY Acad Sci 1972; 203: 237-247.
10. Malmendier C. F., Van den Bergen C. J., Baran D. Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis. Helv paediat Acta 1977; 32: 115-128.
11. Rosenlund M. L., Selekman J. A., Rim H. K., Kritchevsky D. Dietary essential fatty acids in cystic fibrosis. Pediatrics 1977; 59: 423-432.
12. Chase H. P., Dupont J. Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet 1978; ii: 236-238.
13. Hubbard V. S., Dunn G. D., di Sant'Agnese P. A. Abnormal fatty acid composition of plasma lipids in cystic fibrosis. A primary or secondary defect? Lancet 1977; i: 1302-1304.
14. Galabert C., Filliat M., Chazalette J. P. Fatty acid composition of serum lecithins in cystic fibrosis patients without steatorrhea. Lancet 1978; i: 903.
15. Böhles H., Heid H., Stehr K., Fekl W. Deficiencies of essential fatty acids and Vit E in cystic fibrosis. Z Ernär Wissensch 1979; 18:81-87.
16. Hubbard V. S., Dunn G. D., Lester L. A. Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis. Am J Clin Nutr 1980; 33:2281-2286.
17. Lloyd-Still J. D., Johnson S. B., Holman R. T. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 1981; 34: 1-7.
18. Rogiers V., Dab I., Crockaert R., Vis H-L. Long chain non esterified fatty acids in plasma of cystic fibrosis patients and their parents. Pediat Res 1980; 14: 1088-1091.
19. Rogiers V., Vercruysse A., Dab I., Baran D. Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. Eur J Pediatr 1983; 14: 39-42.
20. Farrell P. M., Mischler E. H., Engle M. J., Brown D. J., Lau S.-M. Fatty acid abnormalities in cystic fibrosis. Pediat Res 1985; 19: 104-109.
21. Henker J., Schmike E., Paul K.-D., Leupold W. Fettsäuremuster bei Kindern mit Mukoviscidose in Beziehung zum grad der exokrinen Pankreasinsuffizienz. Helv paediat Acta 1987; 42: 13-20.
22. Biggemann B., Laryea M. D., Schuster A., Griese M., Reinhardt D., Bremer H.J. Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis. Scand J Gastroenterol 1988; 23 (Suppl 143): 134-141.
23. Lepage G., Levy E., Ronco N., Smith L., Galeano N., Roy C. C. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989; 30: 1483-1490.
24. Lloyd-Still J. D., Johnson S. B., Holman R. T. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr 1991 ; 54: 1029-1035.
25. Christophe A., Robberecht E., De Baets F., Franckx H. Increase of long chain omega-3 fatty acids in the major serum lipid classes of patients with cystic fibrosis. Ann Nutr Metab 1992; 36:304-312.
26. Christophe A. B., Warwick W. J., Holman R. T. Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 1994; 29: 569-575.
27. Christophe A., Robberecht E., Franckx H., van de Pas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann Nutr Metab 1994; 38:40-47
28. Hubard V. S., Dunn., G. D. Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis. Clin Chim Acta 1980; 102: 115-118.
29. Rogiers V., Crockaert R., Vis H-L. Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency. Clin Chim Acta 1980; 105: 105-115.
30. Kuo P. T., Huang N. N., Bassett D. R. Effect of impaired fat absorption upon the fatty acid composition of serum chylomicra and adipose tissue in cystic fibrosis of the pancreas. Trans Assoc Am Phys 1961; 54: 147-162.
31. Gershbein L L., Lloyd-Still J. D., Rimkus W. V. Total fatty acids of hair lipids in cystic fibrosis. Biotechnol Appl Biochem 1989; 11: 136-140.
32. Sanjurjo P., Allue X., Rodriguez-Soriano J. Fatty acid composition of lecithin of mucus in cystic fibrosis. Lancet 1977; i: 752.
33. Bitman J., Hamosh W., Wood D. L. et al. Lipid composition of milk from mothers with cystic fibrosis. Pediatrics 1987; 80: 927-932.
34. Lands W. E. M., Libelt B., Morris A. et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992; 1180: 147-160.
35. Horrobin D. F. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res 1992; 31: 163-194.
36. Ackman R. G. UK report on health. ISSFAL Newsletter 1995; 2: 5-8.
37. Bang H. O., Dyerberg J., Sinclair H. M. The composition of Eskimo food in north western Greenland. Am J Clin Nutr 1980; 33: 2657-2661.
38. Kuo P. T., Huang N. N. The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas. J Clin Invest 1965; 44: 1924-1933.
39. Hirono H., Suzuki H., Igarashi Y., Konno T. Essential fatty acid deficiency induced by total parenteral nutrition and by medium-chain triglyceride feeding. Am J Clin Nutr 1977; 30: 1670-1676.
40. Durie P. R., Pencharz P. B. Nutrition. Br Med Bull 1992; 48:823-847
41. Rivers J. P. X., Hassam A. G. Defective essential fatty acid metabolism in cystic fibrosis. Lancet 1975; ii: 642-643.
42. Niessen K. H., Brugmann G., Schmidt K. et al. Fettresorption mit und ohne Pankrcasenzymsubstitution bei Kindern mit zystisher Pankreasfibrose. Klin Pädiat 1973; 185: 271-279.
43. Christophe A. Metabolism and physiological effects of dietary fats in relation to their structure. In: Caragay A., Orthoefer F., eds. Physiologically Functional Foods. Champaign, IL: AOCS Press, 1996: 75-78.
44. Tomarelli R. M., Meyer B. J., Weaber J. R., Bernhart F. W. Effect of positional distribution on the absorption of the fatty acids of human milk and infant formulas. J Nutr 1968; 95: 583-590.
45. IUPAC-IUB Commission on Biochemical Nomenclature. J Lipid Res 1967; 8: 526-529.
46. Dodge J. A., Custance J. M., Goodchild M. C. et al. Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis. Br J Nutr 1990; 63: 259-271.
47. Henderson W. R., Astley S. J., McCready M. M. et al. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr 1994; 124: 400-408.
48. Carlier H., Bernard A., Casseli C. Digestion and absorption of polyunsaturated fatty acids. Rep Nutr Dev 1991; 31: 475-500.
49. Saunders D. R., Sillery J. Lecithin inhibits fatty acid and bile salt absorption from rat small intestine in vivo. Lipids 1976; 11:830-832.
50. Bronstein M. N., Davies P. S., Hambidge K. M., Accurso F.J. Normal energy expenditure in the infant with presymptomatic cystic fibrosis. J Pediatr 1995; 126:28-33.
51. Laing S. C. The nutritional management of children with cystic fibrosis. Human Nutr: Appl Nutr 1986; 40A: 24-31.
52. Thomson M. A., Bucolo S., Quirk P., Shepherd R. W. Measured versus predicted resting energy expenditure in infants: a need to reappraisal. J Pediatr 1995 126: 21-27.
53. Daniels L., Davidson G. P., Cooper D. M. Assesment of nutrient intake of patients with cystic fibrosis compared with healthy children. Human Nutr: Appl Nutr 1987 41A: 151-159.
54. O'Rawe A., Mclntosh I., Dodge J. A. et al. Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci 1992; 82: 71-76.
55. Lloyd-Still J. D., Bohan T., Hoghes S., Wessel H. U. Acylcarnitine is low in cord blood in cystic fibrosis. Acta Paediatr Scand 1990; 79: 427-430.
56. Parsons H. G., O'Loughlin E. V., Forbes D., Cooper D., Gall G. D. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 1988; 24: 353-356.
57. Bezard J., Blond J. P., Bernard A., Clouet P. The metabolism and availability of essential fatty acids in animal and human tissues. Reprod Nutr Dev 1994; 34: 539-568.
58. Hamilton R. M., Gillespie G. T., Cook H. W. Relationship between levels of essential fatty acids and zinc in plasma of cystic fibrosis patients. Lipids 1981; 16: 374-376.
59. Monroy G., Rola F. H., Pullman M. E. A substrate and position specific acylation of sn-glycerol-3-phosphate by rat liver mitochondria. J Biol Chem 1972; 247: 6884-6894.
60. Holman R. T., Johnson S. B. Changes in essential fatty acid profile of serum phospholipids in human disease. Prog Lipid Res 1981; 20: 67-73.
61. Glomset J. A. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155-167.
62. Glatz J. F. C., Soffers A. E. M. F., Katan M. B. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 1989; 49: 269-276.
63. Lévi E., Roy C., Lacaille F. et al. Lipoprotein abnormalities associated with cholesteryl ester transfer protein in cystic fibrosis patients: the role of essential fatty acid deficiency. Am J Clin Nutr 1993; 57: 573-579.
64. Lévi E., Lepage M., Bendayan M. et al. Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients. J Lipid Res 1989; 30: 1197-1209.
65. Lopez S. M., Trimbo S. L., Mascioli E. A. Blackburn G. L. Human plasma fatty acid variations and how they are related to dietary intake. Am J Clin Nutr 1991; 53: 628-637.
66. Holman R. T., Push F., Svingen B., Dutton H.J. Unusual isomeric polyunsaturated fatty acids in liver phospholipids of rats fed hydrogenated oil. Proc Natl Acad Sci USA 1991 ; 88: 4830-4834.
67. Holman R. T., Johnson S. B., Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sd USA 1989; 86: 4720-4724.
68. Garg M. L., Tomson A. B. R., Clandinin M. T. Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J Lipid Res 1990; 31: 271-277.
69. 4 receptor expression in cystic fibrosis. Clin Exp Immunol 1994; 98: 12-16.
70. Strandvik B., Brönnegard M., Gilliam H., Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand J Gastroenterol 1988; 23 (Suppl 143): 1-4.
71. Brown A. J., Roberts D. C. K. Erythrocyte EPA as a marker for intake of fish and fish oil. Eur J Clin Nutr 1990; 44: 487-488.
72. Kerem B. S., Rommens J. M., Buchanan J. A. et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 1988; 245: 1073-1080.
73. Thompson G. N. Relationship between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores. Eur J Pediatr 1989; 148: 327-329.
74. Hubbard V. S. What is the association between essential fatty acid status with cystic fibrosis. Eur J Pediatr 1983; 141: 68-70.
75. Gow R., Francis P., Bradbear A., Shepherd R. Comparative study of varying regimens to improve steatorrhea and creatorrhea in cystic fibrosis: effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet 1981; i: 1071-1074.
76. Robb T. A., Davidson G. P., Kirubakaran C. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Gut 1985; 26: 1246-1256.
77. Brown R. K., Kelly F.J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-493.
78. Winklhofer-Roob B. M. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr 1994; 83 (Suppl 395): 49-57
79. Portal B. C., Richard M. J., Faure H. S., Hadjian A. J., Favier A. E. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843-847.
80. Carlstedt-Duke J., Brönnegard M., Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: The putative genetic defect. Proc Natl Acad Sci USA 1986; 83: 9202-9206.
81. Strandvik B. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand 1989; Suppl 363: 58-63.
82. Holman R. T., Johnson S. B. Essential fatty acid deficiencies in man. In: Perkins E. G., Visek W.J., eds. Dietary Fats and Health. Champaign, IL: AOCS, 1983: 247-266.
83. Paulsrud J. R., Pensler L., Whitten C. F., Steward S., Holman R. T. Essential fatty acid deficiency in infants induced by fat-free intravenous feeding. Am J Clin Nutr 1972; 25: 897-904.
84. Holman R. T., Johnson S. B., Mercuri O., Itarte H. J., Rodrigo M. A., De Tomas M. E. Essential fatty acid deficiency in malnourished children. Am J Clin Nutr 1981; 34: 1534-1539.
85. Holman R. T., Johnson S. B., Ogburn P. L. Deficiencies of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci USA 1991; 88: 4835-4839.
86. Hjelte L., Strandvik B., Muller R. M., Sagstrom S., Roomans G. M. Essential fatty acid deficient rats in the study of cystic fibrosis: an X-ray microanalytical and ultrastructural study in chronically reserpinized rats. J Submicrosc Cytol Pathol 1990; 22: 409-414.
87. Lévi E., Gurbindo C., Lacaille F. et al. Circulating tumor necrosis factor alfa levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 1993; 34: 162-166.
88. Sigstrom L., Strandvik B. Erythrocyte sodium-potassium transport in cystic fibrosis. Pediatr Res 1992; 31: 425-427
89. Strandvik B., Hultcrantz R. Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis. Liver 1994; 14: 32-36.
90. Abuirmeileh N. M., Elson C. E. The influence of linoleic acid intake on membrane-bound respiratory activities. Lipids 1980; 15: 918-931.
91. Parsons G. H., Hill R., Pencharz P., Kuksis A. Modulation of human erythrocyte shape and fatty acids by the diet. Biochim Biophys Acta 1986; 860: 420-427
92. Hopkins D. T., Witter R. L, Neshheim M. C. A respiratory disease syndrome in chickens fed essential fatty acid free diets. Proc Soc Exp Biol Med 1963; 114:82-86.
93. Friedman Z., Rosenberg A. Abnormal lung surfactant related to the essential fatty acid deficiency in the neonate. Pediatrics 1979; 63: 855-859.
94. Coates A. L., Boyce P., Muller D., Mearns M., Godfrey S. The role of nutritional status, airway obstruction, hypoxia, and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis. Acta Paediatr Scand 1980; 69: 353-358.
95. Gibson R. A., Teubner J. K., Haines K., Cooper D. M., Davidson G. P. Relationship between pulmonary function and plasma fatty acid levels in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1986; 5: 408-415.
96. Darmstadt G. L., Schmidt C. P., Wechsler D. S. et al. Dermatitis as a presenting sign of cystic fibrosis. Arch Dermatol 1992; 128: 1389-1390.
97. Belli D. C., Lévy E., Darling P., Leroy C., Lepage G., Giguère R. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pediatrics 1987; 80: 517-523.
98. Colombo C., Arlati S., Cursio L.. et al. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scand J Gastroenterol 1988; 23 (Suppl 143): 151-156.
99. Tompson G. N., Robb T. A., Davidson G. P. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J Pediatr 1987; 111: 501-506.
100. McKenna M. C., Hubbard V. S., Bieri J. G. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. J Pediatr Gastroenterol Nutr 1988; 4: 45-51.
101. Hubard V. S., McKenna M. C. Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis. Lipids 1987; 22: 424-428.
102. Roulet M., Weber A. B., Paridis Y. et al. Gastric emtying and lingual lipase activity in cystic fibrosis. Pediatr Res 1980; 14: 1360-1362.
103. Chase P. H., Welch N. N., Rabaglia M. E., Dupont J. Linoleic acid absorption in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1982; 1: 49-54.
104. Verdonk G., Christophe A., Geers R. Possibilities of semi-synthetic food fats for human nutrition and dietetics: new concepts in the physiopathology of lipid assimilation. In: Kabara ed. Symposium on the Pharmacological Effects of Lipids. Champaign, IL: AOCS, 1978: 192-202.
105. Christophe A., Verdonk G., Robberecht E. Fast improvement of severely disturbed serum fatty acid patterns in cystic fibrosis by means of feeding structure-modified natural fats. Arch Intern Physiol Biochim 1982; 90: B7
106. Christophe A., Verdonk G., Robberecht E., Mahathanakhun R. Effect of supplementing medium chain triglycerides with monoglycerides on severely disturbed serum lipid fatty acid patterns in patients with cystic fibrosis. Ann Nutr Metab 1985; 29: 239-245.
107. Beveridge J. Intralipid and cystic fibrosis. Pediatrics 1976; 58: 465-468.
108. Elliott R. B., Robinson P. G. An unusual clinical course in a child with cystic fibrosis treated with fat emulsion. Arch Dis Childh 1975; 50: 76-78.
109. Kusoffsky E., Strandvik B., Troell S. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983; 2: 434-438.
110. Mansell A. L., Andersen J. C., Muttart C. R. et al. Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis. J Pediatr 1984; 104: 700-705.
111. Parson H. G., Shillabeer G., Rademaker A. W. Early onset of essential fatty acid deficiency in patients with cystic fibrosis receiving a semisynthetic diet. J Pediatr 1984; 105: 958-961.
112. 4. Lancet 1993; 342: 465-469.
113. Stead R. J., Barradas M. A., Mikhailidis D. P. et al. Platelet hyperaggregability in cystic fibrosis. Prostaglandins Leukot Med 1987; 26: 91-103.
114. O'Sullivan B. P., Mong S., Votta B., Schidlow D. V. Reduction of eicosanoid production by essential fatty acid depletion does not attenuate the inflammatory response induced by Pseudomonas aeruginosa pneumonia in rat lung. Prostaglandins Leukot Essential Fatty Acids 1992; 46: 203-210.
115. - and fluid absorption by cultured cystic fibrosis (CPAK-I) cells. Proc Natl Acad Sci USA 1993; 90: 4047-4051.
116. 1 analogue (Misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis. Scand J Gastroenterol 1988; 23 (Suppl 143): 142-147
117. Christophe A. Effects of feeding a supplement of γ-linolenic acid containing oils with fish oil on the fatty acid composition of serum phospholipids in healthy volunteers. In: Huang Y. S., Mills D. E., eds. Gamma-Linolenic Acid: Metabolism and Role in Nutrition and Medicne. Champaign, IL: AOCS Press, 1996: 168-174.
118. Knapp H. R., Melly M. A. Hypotensive effects of omega-3 fatty acids: Mechanistic aspects. World Rev Nutr Diet 1991; 66: 313-328.
119. Knapp H. R. Omega-3 fatty acids in respiratory diseases: a review. J Am Coll Nutr 1995; 14: 18-23.
120. Archer S. L, Johnson G.J., Gebhard R. L. et al. Effect of dietary fish oil on lung lipid profile and hypoxic pulmonary hypertension. J Appl Physiol 1989; 66: 1662-1673.
121. 4 in patients with cystic fibrosis. Pediatr Pulmonol 1994; 18: 211-217.
122. Lloyd-Still J. D., Simon S. H., Wessel H. U., Gibson L. E. Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis. Pediatrics 1979; 64: 50-52.
123. Strandvik B., Berg U., Kallner A., Kusoffsky E. Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 1989; 115: 242-250.
124. Mischler E. H., Parrell S. W., Parrell P. M., Raynor W.J., Lemen R.J. Correction of linoleic acid deficiency in cystic fibrosis. Pediatr Res 1986; 20: 36-41.
125. Elliott R. B. A therapeutic trial of fatty acid supplementation in cystic fibrosis. Pediatrics 1976; 57: 474-479.